ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
62,539.53
-0.49%
S&P 500
5,475.09
0.27%
Dow Jones
39,169.52
0.13%
US Dollar vs Yen
161.666
0.10%
Brent Oil
86.705
0.20%
Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Checkmate Pharmaceuticals Inc (CMPI)

  7. Checkmate Pharmaceuticals Inc (CMPI) ニュース

CMPI

Checkmate Pharmaceuticals (CMPI)

Checkmate Pharmaceuticals Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:CMPI
日付受信時刻ニュースソース見出しコード企業名
2022/06/1021 : 37Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/06/0800 : 40Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/06/0404 : 02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/06/0400 : 42Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3123 : 15Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3123 : 13Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3123 : 12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3123 : 05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3123 : 03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 27Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 26Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3122 : 13Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/3121 : 38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/2706 : 01GlobeNewswire Inc.University of Iowa Holden Comprehensive Cancer Center Presents Preliminary Data from Clinical Trial of Vidutolimod at the 2022 American Society of Clinical Oncology (ASCO) Annual MeetingNASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/2105 : 38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/2105 : 32Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/1305 : 50Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/1305 : 46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/1305 : 30GlobeNewswire Inc.Checkmate Pharmaceuticals Announces First Quarter 2022 Financial Results and Provides Business UpdateNASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/1206 : 03Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/1203 : 58Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/1007 : 59Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/0605 : 23Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/0508 : 31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/0222 : 17Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:CMPICheckmate Pharmaceuticals Inc
2022/05/0220 : 49Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:CMPICheckmate Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CMPI

最近閲覧した銘柄

NASDAQ
QQQ
Invesco QQQ Trust Series 1
NYSE
BAC
Bank of America
CCOM
SILVER
SILVER
CCOM
US500
US 500
AMEX
XLF
Financial Select Sector
NYSE
AXP
American Express
USOTC
RHHBY
Roche (QX)
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
BTCUSD
Bitcoin
NASDAQ
TSLA
Tesla
COIN
ETHUSD
Ethereum
NYSE
MCD
McDonalds
SPI
SP500
S&P 500
NYSE
XOM
Exxon Mobil
AMEX
SPY
SPDR S&P 500
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有